North America Specialist Sales 21 July 2026 Elif Korkmaz - Specialist Sales - US Healthcare AC elif.korkmaz@jpmorgan.com J.P. Morgan Securities LLC JPM | DHR 2Q First Take - Lower on Bioprocessing Elif Korkmaz +1 (212) 622 2949 elif.korkmaz@jpmorgan.com DHR Spec View - Disappointment in Bioprocessing & Guide Lower DHR shares are down -9.5% pre-market following an unexpected bioprocessing miss in the quarter, alongside lowered guidance for both 3Q and the full year. For FY26, most investors were modeling 3-4 ...